Danaher has appointed Jessica Mega and Pardis Sabeti to its board of directors. Mega has been the chief medical and scientific officer at Verily Life Sciences since October 2015, and was previously a cardiologist and senior investigator at Brigham & Women's. She has also been a faculty member at Harvard Medical School and a senior investigator with the TIMI Study Group. Mega holds degrees from Stanford University, Yale University School of Medicine, and Harvard School of Public Health.
Danaher this week announced a regular quarterly cash dividend of $.18 per share of its common stock, payable on April 24 to shareholders of record on March 27. The company’s board of directors also approved a quarterly cash dividend of $11.785 per share of its 4.75 percent Series A Mandatory Convertible Preferred Stock, payable on April 15 to shareholders of record on March 31.
Cofactor is a large, structured listing of people, places, and things. Here you can find the description of each topic.